Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAching muscles and joints are reported by some people taking Wegovy, though they are not among the most common side effects listed in the medicine's summary of product characteristics. Most achiness on semaglutide has a mundane explanation that has nothing to do with the drug itself — and recognising the difference matters. These are prescription-only medicines that require clinical assessment before you can start them, so any persistent or severe pain should always be discussed with your prescriber. The NHS semaglutide medicines page sets out the full side-effect profile and is the clearest starting point for anyone trying to understand what to expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The assumption many people carry into this question is that semaglutide is directly attacking muscle tissue or inflaming joints. It is a reassuringly easy one to let go of. Wegovy works as a GLP-1 receptor agonist, targeting appetite and satiety pathways rather than the musculoskeletal system. The medicine's UK product information does not list generalised muscle or joint pain among the common or very common side effects, which are dominated by gastrointestinal symptoms: nausea, constipation, diarrhoea and similar. If you are aching, something else is almost certainly at the root of it, and the most likely culprits are practical and fixable.
That said, individual reports of achiness exist, and any symptom that worries you is worth raising with a clinician. Dismissing all pain as expected and harmless is not the right instinct either.
Losing weight changes how your body moves. Joints that spent years absorbing a certain load suddenly have less to carry, ligaments and tendons adapt, and the muscles around them can feel the shift. This is especially true in the legs and lower back during the months of faster loss. The leg-specific aching some people notice on Wegovy often tracks the speed of weight loss rather than the dose of the medicine. As the rate of loss slows and the body stabilises, the soreness usually settles.
There is also a nutritional dimension. When appetite falls sharply and calorie intake drops, protein intake sometimes falls with it. Muscle tissue needs adequate protein to maintain itself. People eating significantly less while on Wegovy without prioritising protein can develop generalised muscle fatigue that reads as achiness, and if you are wondering how Wegovy actually produces weight loss and what that process involves for the body, that page sets it out clearly. Keeping up lean protein, even when you are not hungry, is worth discussing with your prescriber or a dietitian. Strength-based activity alongside treatment helps preserve muscle mass, which the NHS England guidance on weight management injections explicitly supports as part of a healthy treatment approach.
Nausea and reduced appetite are very common, particularly in the first weeks of treatment or after a dose increase. Eating and drinking less than usual can quietly lead to mild dehydration, and dehydration is one of the most consistent triggers for muscle cramps and a general feeling of physical heaviness. If the aching is worst in the mornings, or accompanied by darker urine or headaches, fluid intake is the first thing to examine.
Some people also experience fatigue on Wegovy (listed as a common side effect) and fatigue has a habit of being felt in the body as physical soreness or heaviness in the limbs. It can be hard to tell fatigue from aching when both are present at once. Tracking when the sensation is worst and whether it coincides with low food and fluid days often clarifies the picture.
Temperature sensitivity affects some patients too. Whether that manifests as feeling unusually warm or feeling cold, it can accompany the general sense that the body is working harder than usual during early treatment. Those experiences are covered in separate pages if either sounds familiar.
Not all pain during treatment is benign, and two scenarios call for fast action. Severe, persistent abdominal pain that radiates towards the back, with or without vomiting, is a recognised warning sign for pancreatitis. The MHRA issued a specific Drug Safety Update on this risk for GLP-1 receptor agonists in January 2026: do not wait to see if it passes. Call 111 or go to A&E.
Gallbladder problems are also associated with rapid weight loss in general and can cause sharp pain in the upper right abdomen, sometimes radiating to the shoulder blade. Again, that is a symptom for urgent assessment, not for monitoring at home.
Any musculoskeletal pain that is severe, worsening over time, or preventing normal activity should go back to your prescriber. Mood changes can also accompany treatment; if you notice low mood alongside physical symptoms, our page on semaglutide and emotional wellbeing covers what is known. Suspected side effects can be reported directly to the MHRA via the Yellow Card scheme.
If you are weighing up whether Wegovy is the right fit for you, or whether the side-effect profile suits your situation, our prescribers review every consultation personally on the day it is submitted. Start your free consultation and a clinician (not a form, not an algorithm) will look at your full picture before anything is prescribed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.